Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)

NACompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

June 30, 2015

Study Completion Date

December 31, 2018

Conditions
Gastroesophageal Reflux DiseaseHiatal Hernia
Interventions
PROCEDURE

TIF Procedure

The TIF procedure results in the creation of an esophago-gastric fundoplication extending up to 4 cm above the Z-line and 270 degrees around the esophagus.

Trial Locations (14)

20190

Reston Hospital, Reston

34471

Munroe Regional Hospital, Ocala

38555

Crossville Medical Group, Crossville

42078

Livingston Hospital and Healthcare Services, Inc. CAH, Salem

46342

St Mary's Hospital, Hobart

49010

Allegan Surgical Associates, Allegan

70808

The Surgeons Group of Baton Rouge, Baton Rouge

76014

Ihde Surgical Group, PA, Arlington

76092

Master Center for Minimally Invasive Surgery, Southlake

77030

The University of Texas Health Science Center, Houston

80110

Swedish Medical Center and SurgOne P.C., Englewood

84604

Utah County Surgical Associates, Provo

85281

Tempe St. Luke's Hospital, Tempe

85546

Mt. Graham Regional Medical Center, Safford

Sponsors
All Listed Sponsors
lead

EndoGastric Solutions

INDUSTRY

NCT01118585 - Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD) | Biotech Hunter | Biotech Hunter